SlitC-PlexinA1 mediates iterative inhibition for orderly passage of spinal commissural axons through the floor plate

  1. Hugo Ducuing
  2. Thibault Gardette
  3. Aurora Pignata
  4. Karine Kindbeiter
  5. Muriel Bozon
  6. Olivier Thoumine
  7. Céline Delloye-Bourgeois
  8. Servane Tauszig-Delamasure
  9. Valerie Castellani  Is a corresponding author
  1. Institut NeuroMyoGène - CNRS UMR 5310 - INSERM U1217 de Lyon- UCBL Lyon 1, France
  2. University of Bordeaux, France

Abstract

Spinal commissural axon navigation across the midline in the floor plate requires repulsive forces from local Slit repellents. The long-held view is that Slits push growth cones forward and prevent them from turning back once they became sensitized to these cues after midline crossing. We analyzed with fluorescent reporters Slits distribution and FP glia morphology. We observed clusters of Slit-N and Slit-C fragments decorating a complex architecture of glial basal process ramifications. We found that PC2 proprotein convertase activity contributes to this ligands pattern. Next, we studied Slit-C acting via PlexinA1 receptor shared with another FP repellent, the Semaphorin3B, through generation of a mouse model baring PlexinA1Y1815F mutation abrogating SlitC but not Sema3B responsiveness, manipulations in the chicken embryo and ex vivo live imaging. This revealed a guidance mechanism by which SlitC constantly limits growth cone exploration, imposing ordered and forward-directed progression through aligned corridors formed by FP basal ramifications.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for figures.

Article and author information

Author details

  1. Hugo Ducuing

    Institut NeuroMyoGène - CNRS UMR 5310 - INSERM U1217 de Lyon- UCBL Lyon 1, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Thibault Gardette

    Institut NeuroMyoGène - CNRS UMR 5310 - INSERM U1217 de Lyon- UCBL Lyon 1, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Aurora Pignata

    Institut NeuroMyoGène - CNRS UMR 5310 - INSERM U1217 de Lyon- UCBL Lyon 1, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Karine Kindbeiter

    Institut NeuroMyoGène - CNRS UMR 5310 - INSERM U1217 de Lyon- UCBL Lyon 1, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Muriel Bozon

    Institut NeuroMyoGène - CNRS UMR 5310 - INSERM U1217 de Lyon- UCBL Lyon 1, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Olivier Thoumine

    Interdisciplinary Institute for Neuroscience, University of Bordeaux, Bordeaux, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8041-1349
  7. Céline Delloye-Bourgeois

    Institut NeuroMyoGène - CNRS UMR 5310 - INSERM U1217 de Lyon- UCBL Lyon 1, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Servane Tauszig-Delamasure

    Institut NeuroMyoGène - CNRS UMR 5310 - INSERM U1217 de Lyon- UCBL Lyon 1, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4926-0199
  9. Valerie Castellani

    Institut NeuroMyoGène - CNRS UMR 5310 - INSERM U1217 de Lyon- UCBL Lyon 1, Lyon, France
    For correspondence
    valerie.castellani@univ-lyon1.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9623-9312

Funding

Agence Nationale de la Recherche (ANR-11-IDEX-0007)

  • Valerie Castellani

Fondation pour la Recherche Médicale (Label team)

  • Valerie Castellani

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Paola Bovolenta, CSIC-UAM, Spain

Version history

  1. Received: September 17, 2020
  2. Accepted: December 18, 2020
  3. Accepted Manuscript published: December 21, 2020 (version 1)
  4. Version of Record published: December 31, 2020 (version 2)

Copyright

© 2020, Ducuing et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 849
    Page views
  • 132
    Downloads
  • 3
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hugo Ducuing
  2. Thibault Gardette
  3. Aurora Pignata
  4. Karine Kindbeiter
  5. Muriel Bozon
  6. Olivier Thoumine
  7. Céline Delloye-Bourgeois
  8. Servane Tauszig-Delamasure
  9. Valerie Castellani
(2020)
SlitC-PlexinA1 mediates iterative inhibition for orderly passage of spinal commissural axons through the floor plate
eLife 9:e63205.
https://doi.org/10.7554/eLife.63205

Share this article

https://doi.org/10.7554/eLife.63205

Further reading

    1. Developmental Biology
    2. Neuroscience
    Tariq Zaman, Daniel Vogt ... Michael R Williams
    Research Article

    The cell-type-specific expression of ligand/receptor and cell-adhesion molecules is a fundamental mechanism through which neurons regulate connectivity. Here, we determine a functional relevance of the long-established mutually exclusive expression of the receptor tyrosine kinase Kit and the trans-membrane protein Kit Ligand by discrete populations of neurons in the mammalian brain. Kit is enriched in molecular layer interneurons (MLIs) of the cerebellar cortex (i.e., stellate and basket cells), while cerebellar Kit Ligand is selectively expressed by a target of their inhibition, Purkinje cells (PCs). By in vivo genetic manipulation spanning embryonic development through adulthood, we demonstrate that PC Kit Ligand and MLI Kit are required for, and capable of driving changes in, the inhibition of PCs. Collectively, these works in mice demonstrate that the Kit Ligand/Kit receptor dyad sustains mammalian central synapse function and suggest a rationale for the affiliation of Kit mutation with neurodevelopmental disorders.

    1. Developmental Biology
    2. Neuroscience
    Smrithi Prem, Bharati Dev ... Emanuel DiCicco-Bloom
    Research Article

    Autism spectrum disorder (ASD) is defined by common behavioral characteristics, raising the possibility of shared pathogenic mechanisms. Yet, vast clinical and etiological heterogeneity suggests personalized phenotypes. Surprisingly, our iPSC studies find that six individuals from two distinct ASD-subtypes, idiopathic and 16p11.2 deletion, have common reductions in neural precursor cell (NPC) neurite outgrowth and migration even though whole genome sequencing demonstrates no genetic overlap between the datasets. To identify signaling differences that may contribute to these developmental defects, an unbiased phospho-(p)-proteome screen was performed. Surprisingly despite the genetic heterogeneity, hundreds of shared p-peptides were identified between autism subtypes including the mTOR pathway. mTOR signaling alterations were confirmed in all NPCs across both ASD-subtypes, and mTOR modulation rescued ASD phenotypes and reproduced autism NPC associated phenotypes in control NPCs. Thus, our studies demonstrate that genetically distinct ASD subtypes have common defects in neurite outgrowth and migration which are driven by the shared pathogenic mechanism of mTOR signaling dysregulation.